Moore M C, Godfrey G S, Hewitt P E, Barbara J A
North London, National Blood Service, Colindale, UK.
Vox Sang. 1997;72(2):79-84. doi: 10.1046/j.1423-0410.1997.7220079.x.
To determine whether antibody to hepatitis B core (anti-HBc) reactivity, as a marker of hepatitis B virus infection, reflects a 'lifestyle' risk in donors in North London, we have obtained detailed histories from donors with various manifestations of HBV infection.
Interviews based on a standardised questionnaire were conducted with 70 donors confirmed to be anti-HBc reactive.
Comparison with controls (known to be anti-HBc-negative) and donors reactive for anti-hepatitis-C virus showed that current donor strategies are effective; in our area, reactivity for anti-HBc is not associated with a lifestyle risk for those donors who are unreactive in current mandatory screening tests.
Blood from donors positive for both anti-HBc and anti-HBs should be considered suitable for transfusion purposes. This is consistent with the practice of accepting blood from naturally immune donors for preparation of hepatitis B immunoglobulin.
为了确定作为乙肝病毒感染标志物的乙肝核心抗体(抗-HBc)反应性是否反映了北伦敦献血者的“生活方式”风险,我们已从患有各种乙肝病毒感染表现的献血者那里获取了详细病史。
对70名经确认抗-HBc反应性呈阳性的献血者进行了基于标准化问卷的访谈。
与对照组(已知抗-HBc阴性)以及抗丙型肝炎病毒反应性呈阳性的献血者相比,结果表明当前的献血者筛选策略是有效的;在我们地区,对于那些在当前强制筛查测试中无反应性的献血者而言,抗-HBc反应性与生活方式风险无关。
抗-HBc和抗-HBs均呈阳性的献血者的血液应被视为适合用于输血目的。这与接受来自自然免疫献血者的血液以制备乙肝免疫球蛋白的做法是一致的。